SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:oru-59353"
 

Search: onr:"swepub:oai:DiVA.org:oru-59353" > Novel theranostic o...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005968naa a2200529 4500
001oai:DiVA.org:oru-59353
003SwePub
008170824s2011 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-593532 URI
024a https://doi.org/10.1158/0008-5472.CAN-10-38942 DOI
040 a (SwePub)oru
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Hilvo, Mikau Bio and Process Technology, VTT Technical Research Centre of Finland, Espoo, Finland4 aut
2451 0a Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression
264 1a Philadelphia, PA, USA :b American Association for Cancer Research,c 2011
338 a print2 rdacarrier
520 a Activation of lipid metabolism is an early event in carcinogenesis and a central hallmark of many cancers. However, the precise molecular composition of lipids in tumors remains generally poorly characterized. The aim of the present study was to analyze the global lipid profiles of breast cancer, integrate the results to protein expression, and validate the findings by functional experiments. Comprehensive lipidomics was conducted in 267 human breast tissues using ultraperformance liquid chromatography/ mass spectrometry. The products of de novo fatty acid synthesis incorporated into membrane phospholipids, such as palmitate-containing phosphatidylcholines, were increased in tumors as compared with normal breast tissues. These lipids were associated with cancer progression and patient survival, as their concentration was highest in estrogen receptor-negative and grade 3 tumors. In silico transcriptomics database was utilized in investigating the expression of lipid metabolism related genes in breast cancer, and on the basis of these results, the expression of specific proteins was studied by immunohistochemistry. Immunohistochemical analyses showed that several genes regulating lipid metabolism were highly expressed in clinical breast cancer samples and supported also the lipidomics results. Gene silencing experiments with seven genes [ACACA (acetyl-CoA carboxylase α), ELOVL1 (elongation of very long chain fatty acid-like 1), FASN (fatty acid synthase), INSIG1 (insulin-induced gene 1), SCAP (sterol regulatory element-binding protein cleavage-activating protein), SCD (stearoyl-CoA desaturase), and THRSP (thyroid hormone-responsive protein)] indicated that silencing of multiple lipid metabolism-regulating genes reduced the lipidomic profiles and viability of the breast cancer cells. Taken together, our results imply that phospholipids may have diagnostic potential as well as that modulation of their metabolism may provide therapeutic opportunities in breast cancer treatment.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
700a Denkert, Carstenu Institute of Pathology, Berlin, Germany4 aut
700a Lehtinen, Laurau Bio and Process Technology, VTT Technical Research Centre of Finland, Turku, Finland4 aut
700a Müller, Beritu Institute of Pathology, Berlin, Germany4 aut
700a Brockmöller, Scarletu Institute of Pathology, Berlin, Germany4 aut
700a Seppänen-Laakso, Tuulikkiu Bio and Process Technology, VTT Technical Research Centre of Finland, Espoo, Finland4 aut
700a Budczies, Janu Institute of Pathology, Berlin, Germany4 aut
700a Bucher, Elmaru Bio and Process Technology, VTT Technical Research Centre of Finland, Turku, Finland4 aut
700a Yetukuri, Laxmanu Bio and Process Technology, VTT Technical Research Centre of Finland, Espoo, Finland4 aut
700a Castillo, Sandrau Bio and Process Technology, VTT Technical Research Centre of Finland, Espoo, Finland4 aut
700a Berg, Emiliau Bio and Process Technology, VTT Technical Research Centre of Finland, Espoo, Finland4 aut
700a Nygren, Heliu Bio and Process Technology, VTT Technical Research Centre of Finland, Espoo, Finland4 aut
700a Sysi-Aho, Markou Bio and Process Technology, VTT Technical Research Centre of Finland, Espoo, Finland4 aut
700a Griffin, Julian L.u Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom4 aut
700a Fiehn, Oliveru Genome Center, University of California, Davis CA, United States4 aut
700a Loibl, Sibylleu German Breast Group, GBG-Forschungs GmbH, Neu-Isenburg, Germany4 aut
700a Richter-Ehrenstein, Christianeu cBreast Cancer Center, Charité University Hospital, Berlin, Germany4 aut
700a Radke, Corneliau Institute of Pathology, DRK Klinikum Berlin Köpenick, Berlin, Germany4 aut
700a Hyötyläinen, Tuulia,d 1971-u Örebro universitet,Institutionen för naturvetenskap och teknik,Bio and Process Technology, VTT Technical Research Centre of Finland, Espoo, Finland4 aut0 (Swepub:oru)tihn
700a Kallioniemi, Olliu Bio and Process Technology, VTT Technical Research Centre of Finland, Turku, Finland4 aut
700a Iljin, Kristiinau Bio and Process Technology, VTT Technical Research Centre of Finland, Turku, Finland4 aut
700a Oresic, Matej,d 1967-u Bio and Process Technology, VTT Technical Research Centre of Finland, Espoo, Finland4 aut0 (Swepub:oru)moc
710a Bio and Process Technology, VTT Technical Research Centre of Finland, Espoo, Finlandb Institute of Pathology, Berlin, Germany4 org
773t Cancer Researchd Philadelphia, PA, USA : American Association for Cancer Researchg 71:9, s. 3236-45q 71:9<3236-45x 0008-5472x 1538-7445
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-59353
8564 8u https://doi.org/10.1158/0008-5472.CAN-10-3894

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view